Patrick Chaltin
Patrick Chaltin is Managing Director of CISTIM, based in Brussels, a role he has held since April 2007. Since October 2006 he has also been Managing Director of the Centre for Drug Design and Discovery (CD3), and in May 2025 he joined the board of Enedra Therapeutics.
Earlier in his career he was IP Manager at K.U.Leuven Research & Development from November 2002 to October 2006. He served on the board of Okapi Sciences from October 2008 to January 2014, and on the board of ImCyse from January 2011 to April 2013.
Chaltin completed a Ph.D. in Pharmaceutical Sciences at KU Leuven between 1997 and 2002, and qualified as a European Patent Attorney through the EPO in 2009.
Career
Roles
- Enedra TherapeuticsBoard MemberMay 2025 – Present
CISTIMManaging DirectorApr 2007 – Present
- Centre for Drug Design and Discovery (CD3)Managing DirectorOct 2006 – Present
- ImCyseMember of the BoardJan 2011 – Apr 2013
- Okapi SciencesMember of the BoardOct 2008 – Jan 2014
- K.U.Leuven Research & DevelopmentIP ManagerNov 2002 – Oct 2006
From public career histories · 8 entries